BG108033A - Използване на 2-амино-1-(4-хидрокси-2-метансулфонамидофенил) етанол за лечение на инконтиненция - Google Patents

Използване на 2-амино-1-(4-хидрокси-2-метансулфонамидофенил) етанол за лечение на инконтиненция

Info

Publication number
BG108033A
BG108033A BG108033A BG10803303A BG108033A BG 108033 A BG108033 A BG 108033A BG 108033 A BG108033 A BG 108033A BG 10803303 A BG10803303 A BG 10803303A BG 108033 A BG108033 A BG 108033A
Authority
BG
Bulgaria
Prior art keywords
hydroxy
ethanol
amino
methanesulfonamidophenyl
incontinence treatment
Prior art date
Application number
BG108033A
Other languages
Bulgarian (bg)
English (en)
Inventor
Pascale Pouzet
Franz Esser
Hisato Kitagawa
Naoki Ishiguro
Ikunobu Maramatsu
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co.Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co.Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co.Kg
Publication of BG108033A publication Critical patent/BG108033A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/31Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
    • C07C311/35Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG108033A 2001-02-01 2003-07-28 Използване на 2-амино-1-(4-хидрокси-2-метансулфонамидофенил) етанол за лечение на инконтиненция BG108033A (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10104369A DE10104369A1 (de) 2001-02-01 2001-02-01 Verwendung von 2-Amino-(4-hydroxy-2-methansulfonamidophenyl)ethanol zur Behandlung der Harninkontinenz

Publications (1)

Publication Number Publication Date
BG108033A true BG108033A (bg) 2004-12-30

Family

ID=7672382

Family Applications (1)

Application Number Title Priority Date Filing Date
BG108033A BG108033A (bg) 2001-02-01 2003-07-28 Използване на 2-амино-1-(4-хидрокси-2-метансулфонамидофенил) етанол за лечение на инконтиненция

Country Status (26)

Country Link
EP (1) EP1363614B1 (cs)
JP (1) JP2004517158A (cs)
KR (1) KR20030075173A (cs)
CN (1) CN1489459A (cs)
AR (1) AR035778A1 (cs)
AT (1) ATE293966T1 (cs)
BG (1) BG108033A (cs)
BR (1) BR0206854A (cs)
CA (1) CA2434565A1 (cs)
CZ (1) CZ20032097A3 (cs)
DE (2) DE10104369A1 (cs)
DK (1) DK1363614T3 (cs)
EA (1) EA200300789A1 (cs)
EC (1) ECSP034684A (cs)
EE (1) EE200300357A (cs)
ES (1) ES2240708T3 (cs)
HU (1) HUP0302752A2 (cs)
IL (1) IL156730A0 (cs)
MX (1) MXPA03006816A (cs)
NO (1) NO20033428L (cs)
PL (1) PL361731A1 (cs)
PT (1) PT1363614E (cs)
SK (1) SK9772003A3 (cs)
UY (1) UY27145A1 (cs)
WO (1) WO2002060421A2 (cs)
ZA (1) ZA200305201B (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10352132A1 (de) * 2003-11-04 2005-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Zusammensetzung aus einem Beta-3-Adrenozeptor-Agonisten und einem Alpha Agonisten
CN113413393B (zh) * 2013-08-19 2025-03-04 塔里斯生物医药公司 多单元药物递送装置和方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US341584A (en) * 1886-05-11 Device foe
GB993584A (cs) * 1962-01-24
KR0150649B1 (ko) * 1990-02-07 1998-10-15 아만 히데아키 술폰아닐리드 유도체 및 의약
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
WO1996038143A1 (en) * 1995-06-02 1996-12-05 Synaptic Pharmaceutical Corporation The use of alpha-1c-selective adrenoceptor agonists for the treatment of urinary incontinence
FR2737494B1 (fr) * 1995-08-04 1997-08-29 Synthelabo Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
WO2000010557A1 (fr) * 1998-08-25 2000-03-02 Nippon Shinyaku Co.,Ltd. Preparations solides stabilisees

Also Published As

Publication number Publication date
UY27145A1 (es) 2002-08-30
ECSP034684A (es) 2003-08-29
NO20033428D0 (no) 2003-07-31
DE60203882D1 (de) 2005-06-02
PT1363614E (pt) 2005-06-30
HUP0302752A2 (hu) 2003-11-28
CN1489459A (zh) 2004-04-14
MXPA03006816A (es) 2004-05-14
SK9772003A3 (sk) 2005-03-04
PL361731A1 (en) 2004-10-04
DE10104369A1 (de) 2002-08-08
NO20033428L (no) 2003-09-30
JP2004517158A (ja) 2004-06-10
EP1363614B1 (en) 2005-04-27
EP1363614A2 (en) 2003-11-26
EE200300357A (et) 2003-10-15
IL156730A0 (en) 2004-02-08
KR20030075173A (ko) 2003-09-22
BR0206854A (pt) 2004-01-13
EA200300789A1 (ru) 2004-02-26
WO2002060421A2 (en) 2002-08-08
ES2240708T3 (es) 2005-10-16
CZ20032097A3 (cs) 2003-12-17
WO2002060421A3 (en) 2002-12-19
CA2434565A1 (en) 2002-08-08
DK1363614T3 (da) 2005-05-30
DE60203882T2 (de) 2006-02-02
ATE293966T1 (de) 2005-05-15
AR035778A1 (es) 2004-07-14
ZA200305201B (en) 2004-05-17

Similar Documents

Publication Publication Date Title
ATE408601T1 (de) Fredericamycin-derivate
BR0314603A (pt) Uso de inibidores da sìntese de citoquina para o tratamento de distúrbios de olhos secos
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
BR0208373A (pt) Inibidores da tirosina cinase
EE200400020A (et) Asendatud oksasolidinoonid kombineeritud raviks
DK1343492T3 (da) Behandling af mucositis
BR0210013A (pt) Gel oftálmico de pirenzepina
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
SE0101932D0 (sv) Pharmaceutical combinations
CY1110130T1 (el) Παραγωγα μορφολινης για χρηση ως αγωνιστες ντοπαμινης στην θεραπευτικη αγωγη σεξουαλικης δυσλειτουργιας i.α.
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
BRPI0508051A (pt) derivados de heteroarilaminopirazol utilizáveis para o tratamento de diabetes
BR0017157A (pt) Derivados de 6-hidroxi-indazol para o tratamento de glaucoma
BRPI0415390A (pt) compostos de pirazinona substituìda para o tratamento da inflamação
SE9902267D0 (sv) New compounds
DK1305037T3 (da) Smertestillende medikament
DK1438034T3 (da) Anvendelse af -phenyl-3-dimethylaminiopropanforbindelser til behandling af urininkontinens
EA200200853A1 (ru) Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака
BG108033A (bg) Използване на 2-амино-1-(4-хидрокси-2-метансулфонамидофенил) етанол за лечение на инконтиненция
NO20032411L (no) Anvendelse av substituerte 6-dimetylaminometyl-1-fenyl- cykloheksan-forbindelser for behandling av urininkontinens
CY1105317T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
IT1320192B1 (it) Composizione terapeutica per la cura della psoriasi.
DK1455770T3 (da) Anvendelse af norepinephringenoptagelsesinhibitorer til behandling af tic lidelser
DK1368023T3 (da) Anvendelse af buprenoprphin til behandling af urininkontinens
ATE341323T1 (de) Verwendung von darifenacin zur behandlung des harndrangs